Steven D Rubin Insider Trading Transactions
Get free email notifications about insider trading for Steven D Rubin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven D Rubin. Steven D Rubin is Director in DREAMS INC ($DRMS) and Exec. VP - Admin. & Sec. in Opko Health, Inc. ($EXEG) and Executive VP-Administration in Opko Health, Inc. ($EXEG) and Interim CEO and Interim CFO in Tiger X Medical, Inc. ($CLIK) and in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Sevion Therapeutics, Inc. ($SVON) and Director in PROLOR Biotech, Inc. ($PBTH) and Director in Castle Brands Inc ($ROX) and Director in VBI Vaccines Inc/BC ($VBIV) and in ChromaDex Corp. ($CDYE3) and Director in ChromaDex Corp. ($CDXC) and in Cocrystal Pharma, Inc. ($BZNE) and Director in Cocrystal Pharma, Inc. ($COCP) and Director in IDI, Inc. ($IDI) and Director in Red Violet, Inc. ($RDVT).
Latest Insider Trading Transactions of Steven D Rubin
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCDA, ROX, CDXC, COCP, DRMS, ELOX, FLNT, EXEG, PBTH, RDVT, VBIV
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | CDXC | ChromaDex Corp. | Rubin Steven D | Director | Option Exercise | A | 9.99 | 20,000 | 199,800 | 20,000 | |
Feb 22 2021 | EXEG | OPKO HEALTH, INC. | Rubin Steven D | Executive VP-Admini ... | Option Exercise | A | 4.81 | 350,000 | 1,683,500 | 350,000 | |
Nov 24 2020 | RDVT | Red Violet, Inc. | Rubin Steven D | Director | Grant | A | 0.00 | 7,000 | 0 | 112,638 | 105.6 K to 112.6 K (+6.63 %) |
Aug 27 2020 | EXEG | OPKO HEALTH, INC. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 4.01 | 2,500 | 10,025 | 6,167,732 | 6.2 M to 6.2 M (+0.04 %) |
Aug 27 2020 | EXEG | OPKO HEALTH, INC. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 3.99 | 2,500 | 9,968 | 6,165,232 | 6.2 M to 6.2 M (+0.04 %) |
Aug 27 2020 | EXEG | OPKO HEALTH, INC. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 3.99 | 5,000 | 19,950 | 6,162,732 | 6.2 M to 6.2 M (+0.08 %) |
Jun 24 2020 | COCP | Cocrystal Pharma, ... | Rubin Steven D | Director | Option Exercise | A | 1.33 | 72,000 | 95,760 | 72,000 | |
Jun 23 2020 | CDXC | ChromaDex Corp. | Rubin Steven D | Option Exercise | A | 4.67 | 20,000 | 93,400 | 20,000 | ||
Jun 08 2020 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Option Exercise | A | 2.27 | 350,000 | 794,500 | 350,000 | |
May 26 2020 | ELOX | Eloxx Pharmaceutic ... | Rubin Steven D | Option Exercise | A | 3.39 | 20,000 | 67,800 | 20,000 | ||
Oct 30 2019 | RDVT | Red Violet, Inc. | Rubin Steven D | Director | Grant | A | 0.00 | 12,500 | 0 | 105,638 | 93.1 K to 105.6 K (+13.42 %) |
Oct 25 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 1.50 | 15,000 | 22,500 | 5,744,147 | 5.7 M to 5.7 M (+0.26 %) |
Oct 25 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 1.50 | 15,000 | 22,500 | 5,744,147 | 5.7 M to 5.7 M (+0.26 %) |
Oct 25 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Option Exercise | A | 2.47 | 250,000 | 617,500 | 250,000 | |
Oct 09 2019 | ROX | Castle Brands Inc | Rubin Steven D | Director | Option Exercise | D | 1.04 | 20,000 | 20,800 | 0 | |
Oct 09 2019 | ROX | Castle Brands Inc | Rubin Steven D | Director | Option Exercise | D | 0.84 | 20,000 | 16,800 | 0 | |
Oct 09 2019 | ROX | Castle Brands Inc | Rubin Steven D | Director | Option Exercise | D | 1.46 | 20,000 | 29,200 | 0 | |
Oct 09 2019 | ROX | Castle Brands Inc | Rubin Steven D | Director | Option Exercise | D | 1.07 | 20,000 | 21,400 | 0 | |
Oct 09 2019 | ROX | Castle Brands Inc | Rubin Steven D | Director | Option Exercise | D | 0.29 | 20,000 | 5,800 | 0 | |
Oct 09 2019 | ROX | Castle Brands Inc | Rubin Steven D | Director | Option Exercise | D | 0.27 | 20,000 | 5,400 | 0 | |
Oct 09 2019 | ROX | Castle Brands Inc | Rubin Steven D | Director | Option Exercise | D | 0.29 | 20,000 | 5,800 | 0 | |
Oct 09 2019 | ROX | Castle Brands Inc | Rubin Steven D | Director | Sell | D | 1.27 | 22,500 | 28,575 | 0 | 22.5 K to 0 (-100.00 %) |
Oct 09 2019 | ROX | Castle Brands Inc | Rubin Steven D | Director | Sell | U | 1.27 | 108,500 | 137,795 | 22,500 | 131 K to 22.5 K (-82.82 %) |
Aug 05 2019 | RDVT | Red Violet, Inc. | Rubin Steven D | Director | Grant | A | 0.00 | 8,334 | 0 | 68,472 | 60.1 K to 68.5 K (+13.86 %) |
Aug 05 2019 | RDVT | Red Violet, Inc. | Rubin Steven D | Director | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Jul 03 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Option Exercise | A | 2.47 | 250,000 | 617,500 | 250,000 | |
Jun 24 2019 | CDYE3 | ChromaDex Corp. | Rubin Steven D | Option Exercise | A | 3.80 | 20,000 | 76,000 | 20,000 | ||
May 29 2019 | ELOX | Eloxx Pharmaceutic ... | Rubin Steven D | Option Exercise | A | 9.02 | 20,000 | 180,400 | 20,000 | ||
May 10 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 2.15 | 7,200 | 15,480 | 5,729,147 | 5.7 M to 5.7 M (+0.13 %) |
May 10 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 2.13 | 2,600 | 5,538 | 5,721,947 | 5.7 M to 5.7 M (+0.05 %) |
May 10 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 2.12 | 200 | 424 | 5,719,347 | 5.7 M to 5.7 M (0.00 %) |
Mar 07 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 2.56 | 2,435 | 6,234 | 5,719,147 | 5.7 M to 5.7 M (+0.04 %) |
Mar 07 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 2.56 | 2,435 | 6,234 | 5,719,147 | 5.7 M to 5.7 M (+0.04 %) |
Mar 07 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 2.56 | 5,565 | 14,219 | 5,716,712 | 5.7 M to 5.7 M (+0.10 %) |
Mar 07 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 2.56 | 5,565 | 14,219 | 5,716,712 | 5.7 M to 5.7 M (+0.10 %) |
Mar 01 2019 | ROX | Castle Brands Inc | Rubin Steven D | Director | Grant | A | 0.00 | 15,000 | 0 | 131,000 | 116 K to 131 K (+12.93 %) |
Feb 05 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Option Exercise | M | 0.66 | 24,877 | 16,419 | 0 | |
Feb 05 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Payment of Exercise | F | 3.59 | 5,645 | 20,266 | 5,711,147 | 5.7 M to 5.7 M (-0.10 %) |
Feb 05 2019 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | M | 0.66 | 24,877 | 16,419 | 5,716,792 | 5.7 M to 5.7 M (+0.44 %) |
Jan 18 2019 | ROX | Castle Brands Inc | Rubin Steven D | Director | Option Exercise | M | 0.23 | 100,000 | 23,000 | 0 | |
Jan 18 2019 | ROX | Castle Brands Inc | Rubin Steven D | Director | Buy | M | 0.23 | 100,000 | 23,000 | 116,000 | 16 K to 116 K (+625.00 %) |
Sep 24 2018 | COCP | Cocrystal Pharma, ... | Rubin Steven D | Director | Option Exercise | A | 2.78 | 50,000 | 139,000 | 50,000 | |
Jun 26 2018 | CDYE3 | ChromaDex Corp. | Rubin Steven D | Option Exercise | A | 3.83 | 20,000 | 76,600 | 20,000 | ||
Jun 22 2018 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Option Exercise | A | 4.46 | 300,000 | 1,338,000 | 300,000 | |
Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Rubin Steven D | Director | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Option Exercise | M | 0.00 | 18,750 | 0 | 18,750 | |
Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Buy | M | 0.00 | 18,750 | 0 | 56,250 | 37.5 K to 56.3 K (+50.00 %) |
Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Option Exercise | M | 0.00 | 18,750 | 0 | 18,750 | |
Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Buy | M | 0.00 | 18,750 | 0 | 56,250 | 37.5 K to 56.3 K (+50.00 %) |
Apr 02 2018 | RDVT | Red Violet, Inc. | Rubin Steven D | Director | Grant | A | 0.00 | 8,000 | 0 | 4,000 | -4,000 to 4 K (-200.00 %) |
Apr 02 2018 | RDVT | Red Violet, Inc. | Rubin Steven D | Director | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
Apr 02 2018 | RDVT | Red Violet, Inc. | Rubin Steven D | Director | Grant | A | 0.00 | 8,000 | 0 | 4,000 | -4,000 to 4 K (-200.00 %) |
Apr 02 2018 | RDVT | Red Violet, Inc. | Rubin Steven D | Director | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
Mar 08 2018 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 3.25 | 6,000 | 19,500 | 5,691,915 | 5.7 M to 5.7 M (+0.11 %) |
Mar 05 2018 | ROX | Castle Brands Inc | Rubin Steven D | Director | Grant | A | 0.00 | 15,000 | 0 | 16,000 | 1,000 to 16 K (+1,500.00 %) |
Jan 25 2018 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Option Exercise | A | 4.19 | 75,000 | 314,250 | 75,000 | |
Dec 21 2017 | SVON | Sevion Therapeutic ... | Rubin Steven D | Director | Option Exercise | A | 6.00 | 43,189 | 259,134 | 43,189 | |
Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Option Exercise | M | 0.00 | 18,750 | 0 | 37,500 | |
Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Buy | M | 0.00 | 18,750 | 0 | 37,500 | 18.8 K to 37.5 K (+100.00 %) |
Jun 01 2017 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 6.10 | 2,000 | 12,200 | 5,685,915 | 5.7 M to 5.7 M (+0.04 %) |
May 11 2017 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 6.91 | 1,419 | 9,805 | 5,683,915 | 5.7 M to 5.7 M (+0.02 %) |
May 11 2017 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 6.90 | 581 | 4,009 | 5,682,496 | 5.7 M to 5.7 M (+0.01 %) |
Apr 17 2017 | COGT | Cogint, Inc. | Rubin Steven D | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Apr 17 2017 | COGT | Cogint, Inc. | Rubin Steven D | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Apr 13 2017 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Option Exercise | M | 2.36 | 265,000 | 625,400 | 0 | |
Apr 13 2017 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Payment of Exercise | F | 7.66 | 158,336 | 1,212,854 | 5,681,915 | 5.8 M to 5.7 M (-2.71 %) |
Apr 13 2017 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | M | 2.36 | 265,000 | 625,400 | 5,840,251 | 5.6 M to 5.8 M (+4.75 %) |
Apr 07 2017 | CDYE3 | ChromaDex Corp. | Rubin Steven D | Option Exercise | A | 2.58 | 40,000 | 103,200 | 40,000 | ||
Mar 31 2017 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Option Exercise | A | 3.79 | 12,500 | 47,375 | 12,500 | |
Mar 01 2017 | ROX | Castle Brands Inc | Rubin Steven D | Director | Option Exercise | A | 1.04 | 20,000 | 20,800 | 20,000 | |
Feb 16 2017 | SVON | Sevion Therapeutic ... | Rubin Steven D | Director | Option Exercise | A | 0.22 | 160,227 | 35,250 | 160,227 | |
Feb 09 2017 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 8.11 | 2,000 | 16,214 | 5,575,251 | 5.6 M to 5.6 M (+0.04 %) |
Jan 03 2017 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 9.18 | 2,000 | 18,353 | 5,573,251 | 5.6 M to 5.6 M (+0.04 %) |
Aug 12 2016 | CLIK | Tiger X Medical, I ... | Rubin Steven D | Interim CEO and Int ... | Grant | A | 0.00 | 200,000 | 0 | 302,822 | 102.8 K to 302.8 K (+194.51 %) |
Jun 15 2016 | SVON | Sevion Therapeutic ... | Rubin Steven D | Director | Option Exercise | A | 0.22 | 89,773 | 19,750 | 89,773 | |
Jun 03 2016 | IDI | IDI, Inc. | Rubin Steven D | Director | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
May 05 2016 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Option Exercise | M | 1.16 | 250,000 | 290,000 | 0 | |
May 05 2016 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Payment of Exercise | F | 10.34 | 134,918 | 1,395,052 | 5,557,489 | 5.7 M to 5.6 M (-2.37 %) |
May 05 2016 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | M | 1.16 | 250,000 | 290,000 | 5,692,407 | 5.4 M to 5.7 M (+4.59 %) |
Apr 01 2016 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Option Exercise | A | 10.41 | 450,000 | 4,684,500 | 450,000 | |
Mar 31 2016 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 10.17 | 1,000 | 10,166 | 5,442,407 | 5.4 M to 5.4 M (+0.02 %) |
Mar 17 2016 | BZNE | Cocrystal Pharma, ... | Rubin Steven D | Buy | P | 0.51 | 39,216 | 20,000 | 93,564 | 54.3 K to 93.6 K (+72.16 %) | |
Mar 21 2016 | ROX | Castle Brands Inc | Rubin Steven D | Director | Option Exercise | A | 0.84 | 20,000 | 16,800 | 20,000 | |
Nov 23 2015 | SVON | Sevion Therapeutic ... | Rubin Steven D | Director | Option Exercise | A | 0.50 | 40,000 | 20,000 | 40,000 | |
Sep 25 2015 | IDI | IDI, Inc. | Rubin Steven D | Director | Option Exercise | M | 0.00 | 73,000 | 0 | 0 | |
Sep 25 2015 | IDI | IDI, Inc. | Rubin Steven D | Director | Buy | M | 0.00 | 73,000 | 0 | 163,255 | 90.3 K to 163.3 K (+80.88 %) |
Aug 20 2015 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 12.40 | 1,800 | 22,320 | 5,441,407 | 5.4 M to 5.4 M (+0.03 %) |
Aug 20 2015 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | P | 12.40 | 200 | 2,479 | 5,439,607 | 5.4 M to 5.4 M (0.00 %) |
Jul 30 2015 | IDI | IDI, Inc. | Rubin Steven D | Director | Option Exercise | M | 0.00 | 27,000 | 0 | 0 | |
Jul 30 2015 | IDI | IDI, Inc. | Rubin Steven D | Director | Buy | M | 0.00 | 27,000 | 0 | 90,255 | 63.3 K to 90.3 K (+42.68 %) |
Jun 03 2015 | IDI | IDI, Inc. | Rubin Steven D | Director | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
Apr 15 2015 | BZNE | Cocrystal Pharma, ... | Rubin Steven D | Option Exercise | A | 1.17 | 350,000 | 409,500 | 350,000 | ||
Mar 27 2015 | BZNE | Cocrystal Pharma, ... | Rubin Steven D | Buy | P | 0.92 | 54,348 | 50,000 | 694,268 | 639.9 K to 694.3 K (+8.49 %) | |
Mar 27 2015 | ROX | Castle Brands Inc | Rubin Steven D | Director | Option Exercise | A | 1.46 | 20,000 | 29,200 | 20,000 | |
Mar 24 2015 | IDI | IDI, Inc. | Rubin Steven D | Director | Option Exercise | A | 0.00 | 73,000 | 0 | 73,000 | |
Mar 19 2015 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Option Exercise | A | 14.42 | 450,000 | 6,489,000 | 450,000 | |
Mar 05 2015 | BZNE | Cocrystal Pharma, ... | Rubin Steven D | Option Exercise | M | 0.00 | 536 | 0 | 0 | ||
Mar 05 2015 | BZNE | Cocrystal Pharma, ... | Rubin Steven D | Buy | M | 0.00 | 109,920 | 0 | 639,920 | 530 K to 639.9 K (+20.74 %) | |
Aug 16 2011 | PBTH | PROLOR Biotech, In ... | Rubin Steven D | Director | Option Exercise | A | 5.47 | 25,000 | 136,750 | 25,000 | |
Jul 27 2009 | PBTH | PROLOR Biotech, In ... | Rubin Steven D | Director | Option Exercise | P | 1.00 | 2,500 | 2,500 | 2,500 | |
Aug 13 2008 | DRMS | DREAMS INC | Rubin Steven D | Director | Option Exercise | A | 1.15 | 10,000 | 11,500 | 20,000 | |
Jul 16 2007 | EXEG | Opko Health, Inc. | Rubin Steven D | Exec. VP - Admin. & ... | Buy | P | 1.80 | 50,000 | 90,000 | 4,145,581 | 4.1 M to 4.1 M (+1.22 %) |
Jun 26 2007 | DRMS | DREAMS INC | Rubin Steven D | Director | Option Exercise | A | 2.64 | 10,000 | 26,400 | 10,000 |
Page: 1